Description
Powerful triple-action peptide that suppresses appetite, increases fat burning, improves metabolism, promotes significant weight loss, enhances blood sugar control, reduces liver fat, and supports overall metabolic health. Suggested Dose: 0.5-12mg weekly (start low and build up as tolerance increases)
Retatrutide – Triple Receptor Agonist Research Compound – 10mg
Retatrutide 10mg is a next-generation synthetic research compound that has gained significant interest due to its ability to interact with three important metabolic signaling pathways: GIP, GLP-1, and glucagon. In laboratory research settings, it is studied to better understand how multiple pathways work together to influence energy balance, nutrient response, and metabolic communication.
Researchers investigate Retatrutide because of its unique multi-receptor activity and its potential to provide insight into complex metabolic processes. Its combination of GIP, GLP-1, and glucagon pathway activity makes it a valuable compound for research focused on metabolism, cellular energy regulation, and endocrine signaling.
Key Features:
- Triple receptor activity targeting GIP, GLP-1, and glucagon pathways
- High-purity 10mg research-grade material
- Studied for metabolic signaling, energy balance, and nutrient response pathways
- Research interest in advanced metabolic and endocrine biology studies
- Intended strictly for laboratory and research use only
Research Use Disclaimer:
This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human consumption, medical use, or veterinary application. Proper handling and compliance with all applicable regulations are required. New to working with lyophilized peptides? Read our Peptide Reconstitution Guide to learn more about the reconstitution process and laboratory considerations.
